Certified by Founder Lodge
Illumina Ventures
United States - San Francisco, CA
INVESTOR
1 Disclosed Funding Rounds $225,000,000
17 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Illumina Ventures is an independently managed firm focused on early-stage companies that are pioneering new applications of genomics and enabling precision medicine.
We invest in life sci
Date | Round | Raised | Participating Investors |
---|---|---|---|
April, 28 ,2023 | Series C | Undisclosed Amount |
Company | Date | Round | Raised |
---|---|---|---|
Broken String Biosciences | September, 19 ,2023 | Series A | $15,000,000 |
Delfi Diagnostics | July, 18 ,2022 | Series B | $225,000,000 |
Pattern Bioscience | April, 28 ,2023 | Series C | $28,700,000 |
Iambic Therapeutics | October, 06 ,2023 | Series B | $100,000,000 |
Pluton Biosciences | May, 25 ,2023 | Series A | $16,500,000 |
Actym Therapeutics, Inc. | October, 20 ,2023 | Series A | $59,500,000 |
Lightcast Discovery | August, 18 ,2023 | Series B | $49,000,000 |
Tagomics | February, 22 ,2024 | Unknown | $8,495,419 |
Broken String Biosciences | September, 19 ,2023 | Series A | $15,000,000 |
Attovia Therapeutics | May, 14 ,2024 | Series B | $105,000,000 |
Iambic Therapeutics | October, 06 ,2023 | Series B | $100,000,000 |
Predicta Biosciences | July, 17 ,2024 | Seed | $5,200,000 |
Actym Therapeutics, Inc. | October, 20 ,2023 | Series A | $59,500,000 |
Tagomics | February, 22 ,2024 | Unknown | $8,495,419 |
Attovia Therapeutics | May, 14 ,2024 | Series B | $105,000,000 |
Predicta Biosciences | July, 17 ,2024 | Seed | $5,200,000 |
Integrated Biosciences, Inc. | October, 04 ,2024 | Seed | $17,000,000 |